Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Battiwalla

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Haematology|April 2, 2002
Allogeneic transplantation using non-myeloablative transplant regimensM Battiwalla, J Barrett
Bone Marrow Transplantation|February 3, 2009
Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practiceM Battiwalla, P L McCarthy
Molecular Medicine Today|January 1, 1997
Gene therapy strategies for leukemiaS E Braun, K Chen, M Battiwalla, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 27, 2014
Persistence of Pseudomonas aeruginosa in a pulmonary nodule with late relapseS Ronkainen, Y Xie, M Battiwalla, et al.
Bone Marrow Transplantation|August 31, 2002
High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantationR Nakamura, K Cortez, S Solomon, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literatureS Padmanabhan, M Battiwalla, T Hahn, et al.
Bone Marrow Transplantation|March 26, 2013
Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survivalZ A McIver, F Yin, T Hughes, et al.
Bone Marrow Transplantation|April 9, 2013
CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CMLS Ito, P Pophali, Wu CO, et al.
Bone Marrow Transplantation|March 7, 2006
Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levelsA Elefante, J Muindi, K West, et al.
Leukemia & Lymphoma|November 3, 2005
Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literatureA Pawarode, M R Baer, S Padmanabhan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Haematology|April 2, 2002
Allogeneic transplantation using non-myeloablative transplant regimensM Battiwalla, J Barrett
Bone Marrow Transplantation|February 3, 2009
Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practiceM Battiwalla, P L McCarthy
Molecular Medicine Today|January 1, 1997
Gene therapy strategies for leukemiaS E Braun, K Chen, M Battiwalla, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 27, 2014
Persistence of Pseudomonas aeruginosa in a pulmonary nodule with late relapseS Ronkainen, Y Xie, M Battiwalla, et al.
Bone Marrow Transplantation|August 31, 2002
High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantationR Nakamura, K Cortez, S Solomon, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literatureS Padmanabhan, M Battiwalla, T Hahn, et al.
Bone Marrow Transplantation|March 26, 2013
Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survivalZ A McIver, F Yin, T Hughes, et al.
Bone Marrow Transplantation|April 9, 2013
CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CMLS Ito, P Pophali, Wu CO, et al.
Bone Marrow Transplantation|March 7, 2006
Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levelsA Elefante, J Muindi, K West, et al.
Leukemia & Lymphoma|November 3, 2005
Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literatureA Pawarode, M R Baer, S Padmanabhan, et al.
Pageof 3